Research
BTIG Research Initiates Coverage on Sensei Biotherapeutics With Buy Rating, $55 Price Target
Sensei Biotherapeutics (SNSE) has an average rating of Buy and mean price target of $51.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$SNSE